Award notice Supplies
Acord-cadru furnizare ANTINEOPLAZICE
Notice published in Romanian. The AI analysis summarises it for you in your language.
- Public buyer
- SPITALUL CLINIC MUNICIPAL CLUJ-NAPOCA
Cluj-Napoca - Place of performance
- Cluj-Napoca
- Estimated value
- €69,269,311 excl. VAT
- Planned end of contract
- 6 October 2028
likely re-tender around April 2028 - Bids received
- 5
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 1 September 2026
- Notice language
- Romanian
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Achizitie ANTINEOPLAZICE 6 loturi conform caiet sarcini-anexa nr.1. Autoritatea contractanta va raspunde in mod clar si complet tuturor solicitarilor de clarificari/informatiilor suplimentare in a 10-a zi inainte de termenul limita stabilit pentru depunerea ofertelor. Numar zile pana la care se pot solicita clarificari inainte de data limita de depunere a ofertelor/candidaturilor: 18
Awarded to
6 lots
- AVELUMABUM CONC. PT. SOL. PERF 20mg/ml-10 ml (200mg)
- CALCII FOLINAS sol inj/perf 10 mg/ml-flacon 10 ml
- DURVALUMABUM conc pt sol perf 50 mg/ml fl a 10 ml (500 mg)
- DOXORUBICINUM conc pt sol perf 2mg/ml- fl 50 ml cu 100 mg
- DOXORUBICINUM( lipozomală polietilenglicată) 2 mg/ml conc. pt. sol. perf.-fl 10ml
- PEMBROLIZUMABUM conc.pt.sol.perf 25mg/ml-4ml (100mg)
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33652100
Similar contracts already awarded
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 600676-2026.